Go to content
UR Home

Combined treatment with MEK and mTOR inhibitors is effective in vitro and in vivo models of hepatocellular carcinoma

URN to cite this document:
urn:nbn:de:bvb:355-epub-415808
DOI to cite this document:
10.5283/epub.41580
Liu, Xianqiong ; Hu, Junjie ; Song, Xinhua ; Utpatel, Kirsten ; Evert, Matthias ; Calvisi, Diego F.
[img]
Preview
License: Creative Commons Attribution 4.0
PDF - Published Version
(7MB)
Date of publication of this fulltext: 13 Feb 2020 10:35


Abstract

Background: Hepatocellular carcinoma (HCC) is the most common primary liver cancer histotype, characterized by high biological aggressiveness and scarce treatment options. Recently, we have established a clinically relevant murine HCC model by co-expressing activated forms of v-akt murine thymoma viral oncogene homolog (AKT) and oncogene c-mesenchymal-epithelial transition (c-Met) proto-oncogenes ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons